• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贫血作为全因死亡率的危险因素:慢性肾脏病的隐匿协同效应

Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.

作者信息

Sato Yuji, Fujimoto Shouichi, Konta Tsuneo, Iseki Kunitoshi, Moriyama Toshiki, Yamagata Kunihiro, Tsuruya Kazuhiko, Narita Ichiei, Kondo Masahide, Kasahara Masato, Shibagaki Yugo, Asahi Koichi, Watanabe Tsuyoshi

机构信息

Dialysis Division, University of Miyazaki Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.

Department of Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki, Miyazaki, 889-1692, Japan.

出版信息

Clin Exp Nephrol. 2018 Apr;22(2):388-394. doi: 10.1007/s10157-017-1468-8. Epub 2017 Aug 16.

DOI:10.1007/s10157-017-1468-8
PMID:28815319
Abstract

BACKGROUND

Anemia is common in chronic kidney disease (CKD) and may be associated with mortality in CKD patients. However, few studies have examined this relationship in Asian populations.

METHODS

A total of 62,931 Japanese people (age 64.0 ± 8.0 years; men 38.5%) were followed up from 2008 to 2012. Participants were divided into six groups in accordance with their estimated glomerular filtration rate (eGFR) (<45, 45-59, ≥60 mL/min/1.73 m) and by hemoglobin levels (13.0 g/dL for men; 12.0 g/dL for women). Hazard ratio and confidence interval (CI) for mortality with a combination of eGFR and anemia were calculated. After matching using propensity score (PS) for anemia, survival analysis between anemic and non-anemic people, independent from some variables, including eGFR, was performed.

RESULTS

A total of 828 (1.3%) participants died (non-anemic vs. anemic, 1.2 vs. 2.3%, p < 0.01). Multivariable Cox analysis showed that, independent of eGFR levels, anemic people had significantly higher mortality. Anemic people were found to have significantly poorer survival than non-anemic people as per a log-rank test (p < 0.01) for the PS-matching cohort. Further stratified logistic analysis using PS in the overall cohort odds ratio (95% CI) showed 2.25 (1.89-2.67) with p < 0.01.

CONCLUSION

The results of the present study showed that anemia was an independent risk factor of all-cause mortality.

摘要

背景

贫血在慢性肾脏病(CKD)中很常见,并且可能与CKD患者的死亡率相关。然而,很少有研究在亚洲人群中探讨这种关系。

方法

对总共62931名日本人(年龄64.0±8.0岁;男性占38.5%)进行了2008年至2012年的随访。参与者根据其估计肾小球滤过率(eGFR)(<45、45 - 59、≥60 mL/min/1.73 m²)和血红蛋白水平(男性为13.0 g/dL;女性为12.0 g/dL)分为六组。计算了eGFR和贫血联合情况下的死亡风险比和置信区间(CI)。在使用贫血倾向评分(PS)进行匹配后,对贫血和非贫血人群进行了生存分析,该分析独立于包括eGFR在内的一些变量。

结果

共有828名(1.3%)参与者死亡(非贫血与贫血,分别为1.2%与2.3%,p<0.01)。多变量Cox分析表明,独立于eGFR水平,贫血人群的死亡率显著更高。对于PS匹配队列,根据对数秩检验(p<0.01)发现贫血人群的生存率明显低于非贫血人群。在总体队列中使用PS进行进一步分层逻辑分析,优势比(95%CI)为2.25(1.89 - 2.67),p<0.01。

结论

本研究结果表明贫血是全因死亡率的独立危险因素。

相似文献

1
Anemia as a risk factor for all-cause mortality: obscure synergic effect of chronic kidney disease.贫血作为全因死亡率的危险因素:慢性肾脏病的隐匿协同效应
Clin Exp Nephrol. 2018 Apr;22(2):388-394. doi: 10.1007/s10157-017-1468-8. Epub 2017 Aug 16.
2
Association between renal function and cardiovascular and all-cause mortality in the community-based elderly population: results from the Specific Health Check and Guidance Program in Japan.社区老年人群中肾功能与心血管疾病及全因死亡率的关联:来自日本特定健康检查与指导项目的结果
Clin Exp Nephrol. 2018 Apr;22(2):346-352. doi: 10.1007/s10157-017-1455-0. Epub 2017 Jul 25.
3
Perioperative and long-term impact of chronic kidney disease on carotid artery interventions.慢性肾脏病对颈动脉介入治疗的围手术期及长期影响。
J Vasc Surg. 2016 Nov;64(5):1295-1302. doi: 10.1016/j.jvs.2016.04.038.
4
Association between responsiveness to methoxy polyethylene glycol-epoetin beta and renal survival in patients with non-dialysis-dependent chronic kidney disease: A pooled analysis of individual patient-level data from clinical trials.非透析依赖性慢性肾脏病患者对聚乙二醇化促红细胞生成素β的反应性与肾脏生存之间的关联:来自临床试验个体患者水平数据的汇总分析
Nephrology (Carlton). 2017 Oct;22(10):769-775. doi: 10.1111/nep.12842.
5
Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia.1期和2期慢性肾脏病2型糖尿病患者的住院治疗及1年全因死亡率:轻度贫血的影响
J Diabetes. 2016 Jul;8(4):502-7. doi: 10.1111/1753-0407.12318. Epub 2015 Jul 30.
6
Implantable cardioverter-defibrillators in patients with CKD: a propensity-matched mortality analysis.慢性肾脏病患者植入式心脏复律除颤器:倾向匹配的死亡率分析
Clin J Am Soc Nephrol. 2015 Jul 7;10(7):1119-27. doi: 10.2215/CJN.11121114. Epub 2015 Jun 25.
7
Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.老年慢性肾脏病男性患者的非酯化脂肪酸与心血管死亡率
Clin J Am Soc Nephrol. 2015 Apr 7;10(4):584-91. doi: 10.2215/CJN.08830914. Epub 2015 Jan 30.
8
Primacy of lowered baseline glomerular filtration rate as a risk for incident chronic kidney disease: A longitudinal study in Japanese subjects.基线肾小球滤过率降低作为新发慢性肾脏病风险因素的首要地位:一项针对日本受试者的纵向研究
Nephrology (Carlton). 2017 Sep;22(9):684-689. doi: 10.1111/nep.12836.
9
Relationship between mortality and speed of eGFR decline in the 3 months prior to dialysis initiation.透析开始前3个月内死亡率与估算肾小球滤过率(eGFR)下降速度之间的关系。
Clin Exp Nephrol. 2017 Feb;21(1):159-168. doi: 10.1007/s10157-016-1262-z. Epub 2016 Apr 15.
10
Ratio of blood urea nitrogen to serum creatinine at initiation of dialysis is associated with mortality: a multicenter prospective cohort study.透析开始时血尿素氮与血清肌酐的比值与死亡率相关:一项多中心前瞻性队列研究。
Clin Exp Nephrol. 2018 Apr;22(2):353-364. doi: 10.1007/s10157-017-1458-x. Epub 2017 Aug 1.

引用本文的文献

1
Mean Corpuscular Volume Is Not a Reliable Predictor of Iron Deficiency in Patients With Chronic Kidney Disease: A Post-Hoc Analysis of the BRIGHTEN Trial.平均红细胞体积并非慢性肾脏病患者缺铁的可靠预测指标:BRIGHTEN试验的事后分析
Cureus. 2025 Apr 28;17(4):e83159. doi: 10.7759/cureus.83159. eCollection 2025 Apr.
2
Explore the effect of HIF-PHI on blood pressure variation rate and anemia efficacy in maintenance hemodialysis patients.探讨缺氧诱导因子脯氨酰羟化酶抑制剂(HIF-PHI)对维持性血液透析患者血压变异性及贫血疗效的影响。
BMC Nephrol. 2025 May 29;26(1):267. doi: 10.1186/s12882-024-03928-w.
3
Macrocytic anemia, kidney dysfunction, and mortality in general population: Japan specific health checkup study.

本文引用的文献

1
Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008-2012.2008 - 2012年日本特定健康检查与指导项目筛查对象的死亡风险
Clin Exp Nephrol. 2017 Dec;21(6):978-985. doi: 10.1007/s10157-017-1392-y. Epub 2017 Mar 3.
2
Cardiovascular events and death in Japanese patients with chronic kidney disease.日本慢性肾脏病患者的心血管事件和死亡。
Kidney Int. 2017 Jan;91(1):227-234. doi: 10.1016/j.kint.2016.09.015. Epub 2016 Nov 22.
3
Significance of estimated glomerular filtration rate in predicting brain or heart attacks in obese and non-obese populations.
一般人群中的大细胞性贫血、肾功能不全与死亡率:日本特定健康检查研究
Sci Rep. 2024 Dec 30;14(1):32005. doi: 10.1038/s41598-024-83547-5.
4
Prevalence, risk factors, and treatment of anemia in hospitalized older patients across geriatric and nephrological settings in Italy.意大利老年医学和肾脏病学环境中住院老年患者贫血的患病率、危险因素和治疗。
Sci Rep. 2024 Aug 24;14(1):19721. doi: 10.1038/s41598-024-70644-8.
5
Clinicopathological features and prognosis of idiopathic membranous nephropathy with thyroid dysfunction.特发性膜性肾病合并甲状腺功能异常的临床病理特征和预后。
Front Endocrinol (Lausanne). 2023 Mar 16;14:1133521. doi: 10.3389/fendo.2023.1133521. eCollection 2023.
6
Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.非透析依赖性慢性肾脏病患者对红细胞生成刺激剂反应低下:BRIGHTEN 研究。
PLoS One. 2022 Nov 29;17(11):e0277921. doi: 10.1371/journal.pone.0277921. eCollection 2022.
7
Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages.低平均 HbA1c 不会增加糖尿病患者的全因和心血管死亡率:贫血和慢性肾脏病分期的影响修饰。
PLoS One. 2022 Aug 11;17(8):e0272137. doi: 10.1371/journal.pone.0272137. eCollection 2022.
8
The Efficacy and Safety of Roxadustat for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis.罗沙司他治疗慢性肾脏病患者贫血的疗效与安全性:一项荟萃分析
Front Pharmacol. 2022 Apr 26;13:779694. doi: 10.3389/fphar.2022.779694. eCollection 2022.
9
Treatment of Anemia in Kidney Disease: Beyond Erythropoietin.肾病贫血的治疗:超越促红细胞生成素
Kidney Int Rep. 2021 Jun 9;6(10):2540-2553. doi: 10.1016/j.ekir.2021.05.028. eCollection 2021 Oct.
10
Estimating the causal effect of transient anemia status on renal and cardiovascular outcomes in community-dwelling patients in Japan at the beginning of impaired renal function using marginal structural modeling.使用边缘结构模型估计在肾功能受损初期的日本社区居住患者中短暂性贫血状态对肾脏和心血管结局的因果效应。
Clin Exp Nephrol. 2022 Feb;26(2):178-189. doi: 10.1007/s10157-021-02137-1. Epub 2021 Oct 1.
估计肾小球滤过率在预测肥胖和非肥胖人群脑卒中和心脏病发作中的意义。
Clin Exp Nephrol. 2015 Oct;19(5):790-6. doi: 10.1007/s10157-014-1062-2. Epub 2014 Nov 30.
4
Impact of metabolic syndrome on the risk of cardiovascular disease mortality in the United States and in Japan.代谢综合征对美国和日本心血管疾病死亡率风险的影响。
Am J Cardiol. 2014 Jan 1;113(1):84-9. doi: 10.1016/j.amjcard.2013.08.042. Epub 2013 Oct 3.
5
U-shaped association between body mass index and proteinuria in a large Japanese general population sample.日本一般人群大样本中体重指数与蛋白尿之间的U型关联。
Clin Exp Nephrol. 2014 Feb;18(1):75-86. doi: 10.1007/s10157-013-0809-5. Epub 2013 May 8.
6
Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria.糖化血红蛋白不如空腹血糖能预测蛋白尿,作为预测糖尿病前期的指标。
Nephrol Dial Transplant. 2012 Oct;27(10):3862-8. doi: 10.1093/ndt/gfs324. Epub 2012 Aug 1.
7
Diagnosis and classification of diabetes mellitus.糖尿病的诊断与分类
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S62-9. doi: 10.2337/dc11-S062.
8
Revised equations for estimated GFR from serum creatinine in Japan.日本基于血清肌酐估算肾小球滤过率的修订方程。
Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1.
9
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.促红细胞生成素通过内皮祖细胞和血管内皮生长因子介导的新生血管形成来改善心脏功能。
Eur Heart J. 2007 Aug;28(16):2018-27. doi: 10.1093/eurheartj/ehm177. Epub 2007 Jun 17.
10
Correction of anemia with epoetin alfa in chronic kidney disease.慢性肾脏病中使用促红细胞生成素α纠正贫血
N Engl J Med. 2006 Nov 16;355(20):2085-98. doi: 10.1056/NEJMoa065485.